CAS NO: | 144875-48-9 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | Resiquimod is aToll-like receptor7 and 8 (TLR7/TLR8) agonist that induces the upregulation of cytokines such as TNF-α,IL-6and IFN-α. | ||||||||||||||||
IC50& Target |
| ||||||||||||||||
体外研究 (In Vitro) | Resiquimod (R-848) induces both hapten- and allergen-specific circulating T cells, including TH2 effectors, to produce IFN-γ and even to lose the ability to produce IL-4[2]. Resiquimod (R848) enhances PBL proliferation in a dose-dependent manner, and increases the number of BrdU-positive cells in BrdU incorporation assay. Cells treated with R848 exhibits significantly increased (3.5-fold) luciferase (a reporter of NF-κB activity) activity[3]. | ||||||||||||||||
体内研究 (In Vivo) | Resiquimod (R-848) (50 μg/bird, i.m. route) significantly up-regulates the expression of IFN-α, IFN-β, IFN-γ, IL-1β, IL-4, iNOS and MHC-II genes in SPF chicken[1]. | ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 314.38 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C17H22N4O2 | ||||||||||||||||
CAS 号 | 144875-48-9 | ||||||||||||||||
中文名称 | 瑞喹莫德;雷西莫特;雷西喹莫特 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMF : 50 mg/mL(159.04 mM;Need ultrasonic) DMSO : ≥ 30 mg/mL(95.43 mM) Methanol : 25 mg/mL(79.52 mM;Need ultrasonic) H2O : 0.1 mg/mL(0.32 mM;Need ultrasonic) *"≥" means soluble, but saturation unknown. 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|